Harbor Capital Advisors’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34K Buy
2,080
+83
+4% +$1.37K ﹤0.01% 735
2026
Q1
$33K Buy
1,997
+392
+24% +$6.13K ﹤0.01% 725
2025
Q4
$24K Sell
1,605
-27
-2% -$382 ﹤0.01% 802
2025
Q3
$21K Buy
1,632
+213
+15% +$2.84K ﹤0.01% 814
2025
Q2
$22K Buy
1,419
+154
+12% +$2.4K ﹤0.01% 789
2025
Q1
$21K Buy
1,265
+661
+109% +$12.2K ﹤0.01% 800
2024
Q4
$11K Sell
604
-398
-40% -$7.67K ﹤0.01% 945
2024
Q3
$19K Buy
+1,002
New +$19.2K ﹤0.01% 834
2023
Q3
Sell
-2,198
Closed -$37.7K 613
2023
Q2
$37.7K Buy
+2,198
New +$34.1K 0.01% 522

Other funds holding SEM

Harbor Capital Advisors's SEM Position: Q2 2026 in Review

Harbor Capital Advisors increased its Select Medical (SEM) stake by 4.2% in Q2 2026, buying an estimated $1.37K and bringing the position to 2,080 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Harbor Capital Advisors first reported a position in SEM in Q2 2023 and has held it in 9 quarters since. The position peaked at $37.7K in Q2 2023. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Harbor Capital Advisors held 2,080 shares of Select Medical worth $34K as of Q2 2026.
  • Harbor Capital Advisors bought 83 Select Medical shares in Q2 2026, an estimated $1.37K.
  • Select Medical made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #735 holding.
  • Harbor Capital Advisors first reported a position in Select Medical in Q2 2023 and has held it in 9 quarters since.
  • Harbor Capital Advisors's Select Medical position peaked at $37.7K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.